S10 Ep33: Levy Lends Insights Into the Current and Future Use of ADCs in NSCLC

OncLive® On Air - A podcast by OncLive® On Air

Podcast artwork

Dr Levy discusses the indication for trastuzumab deruxtecan in HER2+ NSCLC, other ADCs in development, and where the future of ADCs in NSCLC is headed.